Compare Stocks → Don’t expose yourself to stocks during the week (From DTI) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:APOPOTCMKTS:CTTCOTCMKTS:ECIANASDAQ:OBLNNYSE:RMED Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPOPCellect Biotechnology$13.17+0.4%$11.51$6.64▼$35.52$12.87M1.87479,845 shs17,400 shsCTTCCalmare Therapeutics$0.00$0.00▼$0.02N/AN/AN/AN/AECIAEncision$0.70$0.53$0.25▼$0.75$8.24M0.37384 shsN/AOBLNObalon Therapeutics$0.16$4.22$0.66▼$10.77$1.62M-1.237.68 million shs150,245 shsRMEDRa Medical Systems$0.73$0.52▼$11.14$3.19M-0.03197,480 shs77,500 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPOPCellect Biotechnology0.00%0.00%0.00%0.00%0.00%CTTCCalmare Therapeutics0.00%0.00%0.00%0.00%0.00%ECIAEncision0.00%0.00%+52.84%+52.17%+81.44%OBLNObalon Therapeutics-1.82%-7.00%-0.62%-33.81%-94.84%RMEDRa Medical Systems0.00%0.00%0.00%0.00%-61.92%This company has increased its dividend every year for 54 years (Ad)There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.Click here to get them (for Free).MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPOPCellect BiotechnologyN/AN/AN/AN/AN/AN/AN/AN/ACTTCCalmare TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AECIAEncisionN/AN/AN/AN/AN/AN/AN/AN/AOBLNObalon TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ARMEDRa Medical SystemsN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPOPCellect BiotechnologyN/AN/AN/AN/ACTTCCalmare TherapeuticsN/AN/AN/AN/AECIAEncisionN/AN/AN/AN/AOBLNObalon TherapeuticsN/AN/AN/AN/ARMEDRa Medical SystemsN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPOPCellect BiotechnologyN/AN/AN/AN/A$4.77 per shareN/ACTTCCalmare TherapeuticsN/AN/AN/AN/AN/AN/AECIAEncision$7.35M1.12N/AN/A$0.21 per share3.33OBLNObalon Therapeutics$1.59M1.02N/AN/A$0.60 per share0.27RMEDRa Medical Systems$10K0.00N/AN/A$4.29 per share0.00Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPOPCellect Biotechnology-$5.62MN/A0.00∞N/AN/AN/AN/AN/ACTTCCalmare TherapeuticsN/AN/A0.00N/AN/AN/AN/AN/AN/AECIAEncision-$320K-$0.04N/A∞N/A-6.51%-18.97%-10.50%6/20/2024 (Estimated)OBLNObalon Therapeutics-$12.33MN/AN/A∞N/A-776.76%-161.38%-83.58%N/ARMEDRa Medical Systems-$26.86M-$92.36N/AN/AN/AN/A-496.57%-344.49%N/ALatest ECIA, RMED, OBLN, APOP, and CTTC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/14/2024Q3 2024ECIAEncisionN/A-$0.02-$0.02-$0.02N/A$1.58 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPOPCellect BiotechnologyN/AN/AN/AN/AN/ACTTCCalmare TherapeuticsN/AN/AN/AN/AN/AECIAEncisionN/AN/AN/AN/AN/AOBLNObalon TherapeuticsN/AN/AN/AN/AN/ARMEDRa Medical SystemsN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPOPCellect BiotechnologyN/A3.013.01CTTCCalmare TherapeuticsN/AN/AN/AECIAEncision0.112.551.08OBLNObalon TherapeuticsN/A1.861.86RMEDRa Medical SystemsN/A2.862.85OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPOPCellect Biotechnology4.84%CTTCCalmare TherapeuticsN/AECIAEncision8.20%OBLNObalon Therapeutics18.64%RMEDRa Medical Systems11.00%Insider OwnershipCompanyInsider OwnershipAPOPCellect BiotechnologyN/ACTTCCalmare Therapeutics17.50%ECIAEncision40.87%OBLNObalon Therapeutics8.10%RMEDRa Medical Systems18.62%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAPOPCellect Biotechnology2,020977,000N/ANot OptionableCTTCCalmare Therapeutics7N/AN/ANot OptionableECIAEncision3111.78 million6.96 millionNot OptionableOBLNObalon Therapeutics210.02 millionN/ANot OptionableRMEDRa Medical Systems145.37 million4.37 millionNot OptionableECIA, RMED, OBLN, APOP, and CTTC HeadlinesSourceHeadlineDietary Interventions Reduce CVD Risk in RA and SpAajmc.com - March 8 at 7:57 PMAlert1 Medical Alert System Review: What Experts Say (2024)forbes.com - February 20 at 9:27 PMRa Medical Systems Inc.thestreet.com - February 15 at 10:42 AMCatheter Precision Inc (VTAK)investing.com - February 11 at 11:09 PMVTAK Catheter Precision, Inc.seekingalpha.com - January 19 at 6:41 PMWhat Is The Life Expectancy Of Rheumatoid Arthritis? A Review By Doctorsmsn.com - January 7 at 11:58 PMCatheter Precision Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Qfinance.yahoo.com - August 25 at 6:53 PMReminder: Ra Medical Systems Announces Name and Ticker Symbol Changesfinance.yahoo.com - August 17 at 9:15 AMRa Medical Systems, Inc.: Ra Medical Systems Announces Allowance of New Closure Device Patentfinanznachrichten.de - August 16 at 6:14 PMRa Medical Systems Announces Milestone Achievement for Electrophysiology Divisionfinance.yahoo.com - August 7 at 12:14 PMRa Medical Systems, Inc.: Ra Medical Systems Announces Proposed Name and Ticker Symbol Changesfinanznachrichten.de - August 2 at 8:13 AMRa Medical says demand is rising for its non-invasive electrophysiology mapping systemmassdevice.com - July 24 at 5:15 PMRa Medical Systems, Inc.: Ra Medical System's Electrophysiology Division Has Increased Demand for its Non-invasive Mapping Systemfinanznachrichten.de - July 24 at 12:14 PMRa Medical System’s Electrophysiology Division Has Increased Demand for its Non-invasive Mapping Systemfinance.yahoo.com - July 24 at 12:14 PMRa Medical Systems, Inc.: RMED's LockeT Device Utilized in Structural Heart Proceduresfinanznachrichten.de - July 6 at 10:17 AMRMED's LockeT Device Utilized in Structural Heart Proceduresfinance.yahoo.com - July 6 at 10:17 AMInvesting in Ra Medical Systems Inc (RMED): What You Must Knowknoxdaily.com - July 5 at 6:18 PMRa Medical Systems, Inc.: RMED's Electrophysiology Division Submits Data for CE Mark on LockeT Expects to Receive CE Mark in Third Quarter, 2023finanznachrichten.de - June 28 at 9:07 AMRMED's Electrophysiology Division Submits Data for CE Mark on LockeT Expects to Receive CE Mark in Third Quarter, 2023finance.yahoo.com - June 28 at 9:07 AMRa Medical Systems, Inc.: Ra Medical's Electrophysiology Division Announces First Hospital to Complete 100 Procedures Using the VIVO Systemfinanznachrichten.de - June 12 at 4:10 PMRa Medical’s Electrophysiology Division Announces First Hospital to Complete 100 Procedures Using the VIVO Systemfinance.yahoo.com - June 12 at 4:10 PMMedical Device Co. Completes Merger in Q1/23investorideas.com - June 9 at 9:35 PMRa Medical Systems reports Q1 resultsmsn.com - June 5 at 10:34 AMRa Medical Systems, Inc.: Ra Medical Systems Announces First Quarter Resultsfinanznachrichten.de - June 2 at 9:16 PMMedia Sentiment Over TimeTop HeadlinesAkebia Therapeutics Surges on FDA Approval for Anemia TreatmentApril 3, 2024 9:10 AMView Akebia Therapeutics Surges on FDA Approval for Anemia TreatmentHow and When to Roll Your Options Positions? March 27, 2024 9:32 AMView How and When to Roll Your Options Positions? McCormick & Company Stock Isn’t Cheap, But It Is UndervaluedMarch 26, 2024 10:28 AMView McCormick & Company Stock Isn’t Cheap, But It Is UndervaluedDexCom Stock Gains from GLP-1 Diabetic UsersApril 2, 2024 7:16 AMView DexCom Stock Gains from GLP-1 Diabetic UsersSilicon Motion Proves That AI in Motion Stays in MotionApril 16, 2024 11:42 AMView Silicon Motion Proves That AI in Motion Stays in MotionAll Headlines Company DescriptionsCellect BiotechnologyNASDAQ:APOPCellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel.Calmare TherapeuticsOTCMKTS:CTTCCalmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Its flagship medical device is Calmare Pain Therapy Device, a non-invasive and non-addictive modality for the treatment of chronic and neuropathic pain. The company was formerly known as Competitive Technologies, Inc. and changed its name to Calmare Therapeutics Incorporated in August 2014. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut.EncisionOTCMKTS:ECIAEncision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.Obalon TherapeuticsNASDAQ:OBLNObalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity. The company offers the Obalon Balloon System designed to provide weight loss in patients with obesity. Its Obalon Balloon System comprises of a swallowable capsule that contains an inflatable balloon attached to a microcatheter; the Obalon Navigation System console, which is a combination of hardware and software used to track and display the location of the balloon during placement; the Obalon Touch Inflation Dispenser, which is a semi-automated, hand-held inflation device used to inflate the balloon once it is placed; and a disposable canister filled with mixture of gas. Obalon Therapeutics, Inc. was incorporated in 2008 and is headquartered in Carlsbad, California.Ra Medical SystemsNYSE:RMEDRa Medical Systems, Inc develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. Ra Medical Systems, Inc is based in Fort Mill, South Carolina. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.